- within Food, Drugs, Healthcare and Life Sciences topic(s)
- in United Kingdom
- within Food, Drugs, Healthcare and Life Sciences topic(s)
- within Food, Drugs, Healthcare, Life Sciences, Intellectual Property and Insurance topic(s)
In Switzerland, the regulatory landscape governing medicinal products, medical devices, consumer healthcare products, food and nutritional supplements, tobacco, cannabidiol products, cosmetics, biocides, and emerging technologies, such as mobile health, medical apps, wearables, and telemedicine, is highly fragmented. It spans a complex web of statutes, ordinances, guidelines, and international regulations. Navigating these diverse product categories and their intricate regulatory requirements, often marked by nuanced delimitation challenges, requires not only deep legal and regulatory expertise but also substantial practical industry experience. Recent advances in artificial intelligence have further shaped this dynamic field. This article offers an overview of the relevant Swiss regulations, highlights key challenges and pitfalls, and discusses notable recent developments.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
